Life Sciences News | BioTuesdays by Kilmer Lucas IR

Developments

Lucid starts Envoy Medical at buy; PT $2

Lucid Capital Markets initiated coverage of Envoy Medical (NASDAQ:COCH) with a “buy” rating and price target of $2.00. The stock closed at $0.66 on July 24. Screenshot Envoy designs, manufactures, and is working to...

July 27, 2026

Developments

Incisionless TULSA Procedure for prostate cancer demonstrated statistically significant superior penile length preservation compared to Robotic Radical Prostatectomy at 1 month

The title of Profound Medical’s (NASDAQ:PROF; TSX:PRN) press release today, “Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial,” playfully set the tone for its reporting of a sensitive subject: penile...

July 24, 2026

Markets

Rodman & Renshaw starts Zentalis at buy; PT $11

Rodman & Renshaw initiated coverage of Zentalis Pharmaceuticals (NASDAQ: ZNTL) with a “buy” rating and price target of $11.00. The stock closed at $4.50 on July 22. Zentalis is a clinical oncology innovator...

July 23, 2026

Executive Moves

Finance leader Dr. Neera Ravindran joins Unnatural Products as CFO

Closely held Unnatural Products (UNP) has announced the appointment of Neera Ravindran, MD, MBA, as chief financial officer (CFO). Dr. Ravindran brings more than 20 years of deep public markets and private company...

July 22, 2026

Developments

Ukraine MoH Accepts Valion Bio’s Entolimod Dossier for Formal Review Under Regulatory Equivalence Pathway

Valion Bio (NASDAQ: VBIO) has announced that the regulatory dossier for its lead candidate, Entolimod for acute radiation syndrome (ARS), has been accepted by Ukraine’s Ministry of Health (MoH) for formal review...

July 22, 2026

Markets

Clear Street starts Equillium at buy; PT $9

Clear Street initiated coverage of Equillium (NASDAQ: EQ) with a “buy” rating and price target of $9.00. The stock closed at $2.47 on July 20. Equillium is a clinical-stage biotechnology company developing therapies...

July 21, 2026

Developments

Sheba Medical Center to self-sponsor a trial evaluating Valion Bio’s Entolimod in reducing radiation-induced neutropenia and protecting healthy tissue during cancer radiation therapy

Valion Bio (NASDAQ: VBIO) has announced a major clinical development milestone with the finalization of a clinical trial protocol at Sheba Medical Center, one of the world’s leading hospitals, to evaluate...

July 20, 2026

Developments

Casp-Aid appoints Mika Guerard as VP, Head of Drug Development

Closely held Casp-Aid has appointed Mika (Kimiaka C.) Guerard, PhD, MBA, as VP, Head of Drug Development as it makes final preparations to launch a Phase IIb clinical trial evaluating its lead small molecule, CIM765, in...

July 20, 2026

Markets

BTIG starts coverage of two TMS companies at buy, sees anticipated psilocybin therapy approval as potential catalyst for both

BTIG initiated coverage on two companies with “buy” ratings that it believes are undervalued players in the transcranial magnetic stimulation (TMS) space. Analyst Sam Eiber assigns target prices of $5 to Neuronetics...

July 20, 2026

Developments

LIR and OH sign agreement to advance roadmap for transdermal obesity pipeline

LIR Life Sciences (CSE: SKNY; OTCPK: BBCMF) has announced that it has entered into a services agreement with closely held Oxygen Handel GmbH (OH), a specialized preclinical and regulatory development organization, to...

July 17, 2026

Developments

Dimerix acquires Phase 2-ready asset for acute kidney injury

Dimerix (ASX: DXB) has announced that it has acquired DMX-652 for all indications from closely held Mission Therapeutics, expanding its pipeline in rare kidney disease. DMX-652 is a novel first and best-in-class...

July 17, 2026

Developments

Neurology publishes Mobia’s two-year VNS-REHAB data demonstrating sustained stroke recovery

Mobia Medical (NASDAQ: MOBI) has announced the publication of two-year follow-up data from the VNS-REHAB study in Neurology, the peer-reviewed journal of the American Academy of Neurology, demonstrating that...

July 15, 2026

Subscribe